{
  "platform": "linkedin",
  "post_url": "",
  "posted_at": "2025-02-05",
  "campaign_slug": "2025-02-05-titan-nhs-independent-prescribing",
  "asset_type": "carousel",
  
  "boosted": true,
  "sponsored_dates": {
    "start": "2025-02-12",
    "end": "2025-02-13"
  },
  
  "impressions": 5655,
  "reach": 3065,
  "engagements": 3465,
  "engagement_rate": 63.7,
  "clicks": 3394,
  "click_through_rate": 62.4,
  "reactions": 56,
  "comments": 6,
  "reposts": 9,
  "followers_gained": 13,
  "page_views": 19,
  
  "organic": {
    "impressions": 5440,
    "reach": 3065,
    "engagements": 3465,
    "engagement_rate": 63.7,
    "clicks": 3394,
    "click_through_rate": 62.4,
    "reactions": 56,
    "comments": 6,
    "reposts": 9
  },
  
  "sponsored": {
    "impressions": 215,
    "engagements": 38,
    "engagement_rate": 17.7,
    "clicks": 10,
    "click_through_rate": 4.7,
    "reactions": 0,
    "comments": 0,
    "reposts": 0,
    "ecpm": 74.42,
    "cost_per_engagement": 0.42,
    "spend": 74.42
  },
  
  "notes": "Post boosted from 2025-02-12 to 2025-02-13. Exceptional performance: 63.7% engagement rate, 62.4% CTR. High signal asset â€” NHS alignment + future-facing innovation. Social proof from NHS leadership (comments from Ghulam Haydar, Wasim Baqir) boosted confidence and credibility. Strong engagement from policy / tech stakeholders vs typical pharmacist-only audience."
}


